The House Judiciary Committee investigated Pfizer's vaccine timing, with Jim Jordan citing claims about delayed disclosure, while a Pfizer executive moved to GSK.
1 report, 0 independent
Updated Jul 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The House Judiciary Committee investigated Pfizer's vaccine timing, with Jim Jordan citing claims about delayed disclosure, while a Pfizer executive moved to GSK.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- GSK appointed Tina Graves as General Manager for Canadian operations. Graves has experience at both Pfizer and GSK.Sub-event
- House Judiciary Committee investigates Pfizer's vaccine timing, alongside a Pfizer executive moving to GSK.
Keep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
GSK
British multinational pharmaceutical and biotechnology company
-
Jim Jordan
United States Representative from Ohio since 2007
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet